Cancer

Surgery vs Ablation for Small Liver Cancer Shows No Survival Difference

Major trial finds radiofrequency ablation as effective as surgery for small hepatocellular carcinoma, with fewer complications.

Research Paper

Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers

Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.

Mar 29, 2026 12

CAR-T Cell Therapy Shows Promise Against Advanced Liver Cancer in Early Trial

Engineered immune cells target liver cancer protein in phase I safety study, though trial ended early with 10 patients.

New Cancer Drug NKTR-255 Shows Promise in Blood Cancer Treatment Trial

Phase 1 trial tests innovative immunotherapy for multiple myeloma and lymphoma patients who didn't respond to standard treatments.

Wearable Sensors Track Cancer Therapy Side Effects in Real-Time Stanford Study

Stanford researchers used smartwatches and blood tests to monitor dangerous side effects during cutting-edge CAR-T cancer treatment.

Triple Combination Cancer Immunotherapy Shows Promise in Advanced Solid Tumors

Small trial tests novel three-drug approach combining immune checkpoint inhibitor, vaccine, and inflammation blocker for metastatic cancers.

Cancer Immunotherapy May Weaken Bones in Melanoma Survivors

Study examines bone density loss in melanoma patients receiving immune-boosting cancer drugs like nivolumab and pembrolizumab.

Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment

Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.

Mar 29, 2026 0

Cancer Hijacks Immune Cells to Fuel Its Own Growth Through CCL3 Molecule

New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.

Press Release

Mar 29, 2026 12

Nerves Actively Fuel Early Pancreatic Cancer Growth in Surprising Discovery

Scientists discover nerve fibers create a self-sustaining loop that accelerates pancreatic cancer development before tumors even form.

Press Release

Mar 29, 2026 0

Scientists Find Enzyme That Triggers Cancer's Most Chaotic DNA Destruction

Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.

Press Release